Staphylococcus Aureus Caught in Action at the Site of Infection

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 6, 2017

Primary Completion Date

November 23, 2020

Study Completion Date

November 23, 2020

Conditions
Staphylococcus (S.) Aureus Infection
Interventions
OTHER

data collection

Health-related personal data such as year of birth, sex, Body Mass Index (BMI), infection classification, concomitant infections, comorbidities according to medical chart, standard diagnostic markers (CRP, blood differential plots, creatinine, ...), medication, treatment start, treatment end and discharge from hospital will be collected.

DIAGNOSTIC_TEST

blood draw

2 blood drawing events (in total 22.5 ml) will be performed in the patient. 1 blood drawing events will be performed in the healthy proband.

DIAGNOSTIC_TEST

nose swabs

2 nose swabs will be taken in the patient. 1 nose swab will be performed in the healthy proband.

DIAGNOSTIC_TEST

Intraoperative tissue samples

Intraoperative tissue samples from the site of infection during surgery will be taken in the patient.

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04781569 - Staphylococcus Aureus Caught in Action at the Site of Infection | Biotech Hunter | Biotech Hunter